论文部分内容阅读
目的 研究术后早期腹腔内化疗与胃肠肿瘤术后生存率的关系。方法 用术后早期腹腔内化疗并ＭＦ全身化疗的方法治疗了３０ 例经病理确诊的胃肠癌中， Ⅲ～Ⅳ期占８３ ％ 。结果 在３０ 例病人中， １、２ 、５ 年生存率分别为８６－６ ％ ， ６３－３ ％ ， ６－６ ％ ， 其中２ 例胃癌病人生存了６年。结论 术后早期腹腔内化疗并ＭＦ方案全身化疗对胃肠癌术后腹腔复发和肝转移有预防作用。
Objective To study the relationship between early postoperative intraperitoneal chemotherapy and postoperative survival of gastrointestinal cancer. Methods Thirty patients with pathologically confirmed gastrointestinal cancer were treated with intraperitoneal chemotherapy and MF systemic chemotherapy early postoperatively. Stage III-IV accounted for 83%. Results Among the 30 patients, the 1-, 2-, and 5-year survival rates were 86-6 %, 63-3 %, and 6-6 %, respectively. Among them, 2 patients with gastric cancer survived for 6 years. Conclusion Early postoperative intraperitoneal chemotherapy and MF regimen chemotherapy have a preventive effect on peritoneal recurrence and liver metastasis after gastrointestinal cancer.